Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Iradimed (IRMD) FCF Payout Ratio (2022 - 2025)

Iradimed (IRMD) has disclosed FCF Payout Ratio for 4 consecutive years, with 0.17 as the latest value for Q3 2025.

  • On a quarterly basis, FCF Payout Ratio fell 62.22% to 0.17 in Q3 2025 year-over-year; TTM through Sep 2025 was 0.29, a 39.15% decrease, with the full-year FY2024 number at 0.55, down 46.23% from a year prior.
  • FCF Payout Ratio was 0.17 for Q3 2025 at Iradimed, down from 0.42 in the prior quarter.
  • In the past five years, FCF Payout Ratio ranged from a high of 10.6 in Q1 2022 to a low of 0.17 in Q3 2025.
  • A 4-year average of 2.32 and a median of 0.45 in 2024 define the central range for FCF Payout Ratio.
  • Peak YoY movement for FCF Payout Ratio: crashed 72.19% in 2023, then surged 67.49% in 2025.
  • Iradimed's FCF Payout Ratio stood at 10.6 in 2022, then plummeted by 72.19% to 2.95 in 2023, then crashed by 93.79% to 0.18 in 2024, then dropped by 7.57% to 0.17 in 2025.
  • Per Business Quant, the three most recent readings for IRMD's FCF Payout Ratio are 0.17 (Q3 2025), 0.42 (Q2 2025), and 3.64 (Q1 2025).